End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2022 | AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million. | CI |
2019 | Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A. | CI |
Sales 2017 | 7.72M 8.27M 661M | Sales 2018 | 12.59M 13.5M 1.08B | Capitalization | 38.75M 41.53M 3.32B |
---|---|---|---|---|---|
Net income 2017 | - 0 0 | Net income 2018 | 1M 1.07M 85.56M | EV / Sales 2017 | 2.22 x |
Net cash position 2017 | 1.86M 1.99M 159M | Net cash position 2018 | 2.44M 2.61M 209M | EV / Sales 2018 | 2.88 x |
P/E ratio 2017 |
-21.2
x | P/E ratio 2018 |
31.7
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 31.56% |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 22/04/04 | |
Founder | - | 22/04/04 | |
Shinji Mizusawa
BRD | Director/Board Member | - | 01/07/18 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 69.57M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |
- Stock Market
- Equities
- ABB Stock